Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polmacoxib for Post-Operative Pain After Rotator Cuff Tear Surgery
NCT06590714Recruiting
- Sponsor
- Eulji University Hospital
- Start
- Aug 2024
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of polmacoxib in postoperative pain (2 arms), sponsored by Eulji University Hospital. Primary endpoint: Cumulative administration frequency of narcotic analgesics excluding NSAIDs at 3 days. Started Aug 2024; status: recruiting.
02
Drugs
polmacoxib
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06590714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06590714.